SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue slipped marginally during the September 2024 quarter. A decline of about Rs. 403.23 millions was observed as compared to Rs. 406.78 millions during the corresponding quarter last year.The Company has registered profit of Rs. 26.16  millions for the quarter ended September 2024, a growth of 5.31%  over Rs. 24.84 millions millions achieved in the corresponding quarter of last year.Operating profit for the quarter ended September 2024 rose to 48.14 millions as compared to 41.63 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 403.23 406.78 -0.87 736.09 826.25 -10.91 1524.66 1153.50 32.18
Other Income 10.22 1.59 542.77 15.27 20.28 -24.70 35.22 32.73 7.61
PBIDT 48.14 41.63 15.64 65.31 123.26 -47.01 146.34 189.90 -22.94
Interest 6.23 4.38 42.24 12.74 10.39 22.62 22.90 20.38 12.37
PBDT 41.91 37.25 12.51 49.12 112.87 -56.48 123.44 169.52 -27.18
Depreciation 15.75 12.41 26.91 30.19 24.53 23.07 49.95 53.34 -6.36
PBT 26.16 24.84 5.31 18.93 88.34 -78.57 73.49 116.18 -36.74
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.78 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 26.16 24.84 5.31 18.93 88.34 -78.57 73.49 113.40 -35.19
Equity 236.56 236.56 0.00 236.56 236.56 0.00 236.56 236.56 0.00
PBIDTM(%) 11.94 10.23 16.66 8.87 14.92 -40.52 9.60 16.46 -41.70

Bafna Pharma Share Price

145.00 12.40 (9.35%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×